Skip to content

Multi-omic (microbiome, metabolome, and immunome) study of peritumoral lymph nodes in gastric and colorectal cancer.

Multi-omic (microbiome, metabolome, and immunome) study of peritumoral lymph nodes in gastric and colorectal cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073264
Enrollment
Unknown
Registered
2023-07-05
Start date
2023-07-05
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer and colorectal cancer

Interventions

Positive lymph nodes around gastric cancer:None
Negative lymph nodes around gastric cancer:None
Positive lymph nodes around colorectal cancer:None
Negative lymph nodes around colorectal cancer:None

Sponsors

Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Gastric or colorectal cancer confirmed by pathological diagnosis; ? no family history of malignant tumor, no radiotherapy or chemotherapy before surgical resection; ? no use of antibiotics, non-steroidal anti-inflammatory drugs, statins or probiotics within 3 months before sample collection; ? patients received radical resection of tumors, and the pathological tissue samples and clinical data of patients were well preserved; ? The patients were in good general condition, aged 40 to 70 years old, without serious heart, lung, kidney, liver dysfunction and metabolic diseases;

Exclusion criteria

Exclusion criteria: ? The patient had serious heart, lung, kidney, liver dysfunction and metabolic diseases; ? patients with two or more kinds of malignant tumors; ? Participated in other drug clinical investigators in the past three months; ? the investigator considers that it is not suitable to participate in the clinical trial;

Design outcomes

Primary

MeasureTime frame
Lymph nodes pathology diagnosis;Lymph nodes high-throughput sequencing;Metabonomics of lymph nodes;Immunomics of lymph nodes;

Secondary

MeasureTime frame
Blood routine;Liver function;Kidney function;Electrolyte;

Countries

China

Contacts

Public ContactDeng xiaorong

The Second Affiliated Hospital of Nanchang University

dengxr77@163.com+86 138 7088 9003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026